Furthermore, in a recent study, Luteolin was suggested as a chemosensitizer in gastric cancer as Ren et al. 2020 demonstrated the synergistic effect of Oxaliplatin and Luteolin on the inhibition of the proliferation of gastric cancer cells and induced apoptosis in vitro and showed that Luteolin was able to potentiate the sensitivity of SGC-7901 cells to Oxaliplatin via the cytochrome C/caspase pathway [95]. This evidence concerns the gene CYCS and gastric cancer.